InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: A deleted message

Friday, 04/17/2015 11:25:41 PM

Friday, April 17, 2015 11:25:41 PM

Post# of 30046
Cancer can strike Men and Women at any age. Get peace of mind with CANCER 8.


http://www.metropolisindia.com/patients/cancer-eight

Metropolis presents to you a simple blood test (FDA Approved Process) to rule out 8 most prevalent types of cancer: Colon, Lung, Liver, Stomach, Breast, Ovarian, tongue and Pancreas. Just fill the simple form below and our representative will call you to confirm your booking.
- See more at: http://www.metropolisindia.com/patients/cancer-eight#sthash.dQJVuc9C.dpuf


DC You Said: Yes you Do..Follow the money and the Federal Trademarks you understand..memory formerly PLS claims they are a subsidiary of Amarantus..That is completely false ..imo..Cannot find any connection to that scenario..But we know this connection is true and a given....Ownership in a Federal trade name is everything in the real world you understand...Something AMBS is touting...

https://trademarks.justia.com/787/32/lympro-test-78732802.html

DC You Said:

"I do not know who will take the AMBS Diagnostic Division/LymPro, or why it is taking them this long to spin it off. Does it coincide with Provista's stretched time table- I dunno."

"I doubt that Provista will be acquiring LymPro. I also think that they will spin off CIT to focus on their core business expansion plans. It will take deeper pockets at this time, someone familiar will step out from the shadows and claim those prizes."

William has lots and lots of patents and claime to have two for LC Sentinel pending..He also mentioned he was sending the FDA approval to an outside agency that specializes in that process......

"Perhaps the Radient/GCDx/PDx patents are hiding in plain sight, which is often the toughest place to see."





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.